稳健医疗
(300888)
| 流通市值：90.30亿 | | | 总市值：299.61亿 |
| 流通股本：1.76亿 | | | 总股本：5.82亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,605,313,851.05 | 8,977,853,631.73 | 6,070,042,979.07 | 4,033,505,104.33 |
| 营业收入 | 2,605,313,851.05 | 8,977,853,631.73 | 6,070,042,979.07 | 4,033,505,104.33 |
| 二、营业总成本 | 2,256,241,035.86 | 7,996,304,540.94 | 5,429,693,699 | 3,576,014,244.81 |
| 营业成本 | 1,342,833,799.7 | 4,729,562,118.23 | 3,147,921,084.71 | 2,068,470,442.58 |
| 税金及附加 | 23,254,099.44 | 79,905,265.65 | 51,874,966.65 | 36,656,279.12 |
| 销售费用 | 580,406,867.17 | 2,264,147,324.64 | 1,575,884,258.32 | 1,055,741,084.22 |
| 管理费用 | 217,486,714.86 | 673,737,166.83 | 467,737,889.63 | 309,446,026.4 |
| 研发费用 | 92,098,187.41 | 348,163,926.01 | 231,681,326.77 | 143,142,952.33 |
| 财务费用 | 161,367.28 | -99,211,260.42 | -45,405,827.08 | -37,442,539.84 |
| 其中:利息费用 | 15,540,120.9 | 54,863,504.13 | 37,659,208.17 | 24,015,659.66 |
| 其中:利息收入 | 18,036,216.68 | 117,095,211.38 | 89,713,485.54 | 57,012,846.01 |
| 加:公允价值变动收益 | 2,177,697.04 | 2,862,219.03 | 2,742,139.47 | 7,577,712.84 |
| 加:投资收益 | 4,591,020.72 | 75,387,830.93 | 54,167,596.14 | 33,445,096.19 |
| 资产处置收益 | 337,542 | 5,877,157.55 | 2,760,899.31 | 1,930,800.28 |
| 资产减值损失(新) | -33,244,048.58 | -242,895,761.34 | -59,278,366.15 | -55,975,503.16 |
| 信用减值损失(新) | -3,547,069.8 | 444,626.25 | -7,568,820.47 | -8,295,817.44 |
| 其他收益 | 20,983,176.26 | 91,637,936.87 | 50,294,318.36 | 37,282,933.1 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 340,371,132.83 | 914,863,100.08 | 683,467,046.73 | 473,456,081.33 |
| 加:营业外收入 | 1,683,628.34 | 11,926,122.62 | 6,975,454.11 | 6,143,356.51 |
| 减:营业外支出 | 7,775,199.44 | 18,440,910.03 | 7,856,872.48 | 6,218,160.01 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 334,279,561.73 | 908,348,312.67 | 682,585,628.36 | 473,381,277.83 |
| 减:所得税费用 | 72,532,819.09 | 167,642,375.27 | 96,390,675.76 | 67,151,050.24 |
| 六、净利润 | 261,746,742.64 | 740,705,937.4 | 586,194,952.6 | 406,230,227.59 |
| 持续经营净利润 | 261,746,742.64 | 740,705,937.4 | 586,194,952.6 | 406,230,227.59 |
| 归属于母公司股东的净利润 | 248,565,301.08 | 695,378,928.72 | 552,966,991.14 | 384,150,379.21 |
| 少数股东损益 | 13,181,441.56 | 45,327,008.68 | 33,227,961.46 | 22,079,848.38 |
| (一)基本每股收益 | 0.43 | 1.19 | 0.95 | 0.66 |
| (二)稀释每股收益 | 0.43 | 1.19 | 0.95 | 0.66 |
| 八、其他综合收益 | -3,068,774.25 | -13,162,548.61 | -15,872,749.61 | -5,381,735.14 |
| 归属于母公司股东的其他综合收益 | -2,119,288.47 | -4,853,196.54 | -8,897,740.91 | -2,931,540.14 |
| 九、综合收益总额 | 258,677,968.39 | 727,543,388.79 | 570,322,202.99 | 400,848,492.45 |
| 归属于母公司股东的综合收益总额 | 246,446,012.61 | 690,525,732.18 | 544,069,250.23 | 381,218,839.07 |
| 归属于少数股东的综合收益总额 | 12,231,955.78 | 37,017,656.61 | 26,252,952.76 | 19,629,653.38 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-29 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |